Gyre Therapeutics (GYRE) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.31% |
| Dec 31, 2025 | 248.20% |
| Sep 30, 2025 | 59.01% |
| Jun 30, 2025 | -254.65% |
| Mar 31, 2025 | 198.15% |
| Dec 31, 2024 | 16.05% |
| Sep 30, 2024 | 71.15% |
| Jun 30, 2024 | -14.58% |
| Mar 31, 2024 | -639.21% |
| Dec 31, 2023 | 124.80% |
| Sep 30, 2023 | 32.93% |
| Jun 30, 2023 | -5.27% |
| Mar 31, 2023 | 88.95% |
| Jun 30, 2022 | 2,011.46% |
| Mar 31, 2022 | -12.63% |
| Dec 31, 2021 | -59.28% |
| Sep 30, 2021 | -34.25% |
| Jun 30, 2021 | -61.19% |
| Mar 31, 2021 | 0.11% |
| Dec 31, 2020 | 229.55% |
| Sep 30, 2020 | 11.54% |
| Jun 30, 2020 | -187.68% |
| Mar 31, 2020 | 6,132.05% |
| Dec 31, 2019 | -96.99% |
| Sep 30, 2019 | 299.56% |
| Jun 30, 2019 | -57.74% |
| Mar 31, 2019 | 108.50% |
| Dec 31, 2018 | 214.21% |
| Sep 30, 2018 | 94.99% |
| Jun 30, 2018 | -9,146.20% |
| Mar 31, 2018 | 152.90% |
| Dec 31, 2017 | 90.79% |
| Sep 30, 2017 | -1,647,300.00% |
| Jun 30, 2017 | -100.01% |
| Mar 31, 2017 | 16.38% |
| Dec 31, 2016 | 145.11% |
| Sep 30, 2016 | 141.37% |
| Jun 30, 2016 | -52.70% |
| Mar 31, 2016 | -134.37% |
| Dec 31, 2015 | -58.49% |
| Sep 30, 2015 | 9,610.43% |
| Jun 30, 2015 | -225.79% |
| Sep 30, 2014 | -224.55% |
| Jun 30, 2014 | 286.77% |
| Mar 31, 2014 | 120.34% |
| Dec 31, 2013 | -211.29% |
| Sep 30, 2013 | 126.34% |
| Jun 30, 2013 | 232.39% |
| Mar 31, 2013 | -118.02% |
| Dec 31, 2012 | -5.39% |
| Sep 30, 2012 | 3,538.26% |
| Jun 30, 2012 | -93.23% |
| Mar 31, 2012 | 410.00% |
| Dec 31, 2011 | 88.47% |
| Sep 30, 2011 | 38.59% |
| Jun 30, 2011 | -458.55% |
| Mar 31, 2011 | 11.18% |
| Dec 31, 2010 | 68.88% |